Article Information
History
- June 16, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Steven Rodriguez1,
- Luxiang Cao1,
- Gregory T. Rickenbacher1,
- Eric G. Benz1,
- Colin Magdamo1,
- Liliana Ramirez Gomez1,
- Eric H. Holbrook2,
- Alefiya D. Albers1,3,
- Rose Gallagher1,
- M. Brandon Westover1,
- Kyle E. Evans1,
- Daniel J. Tatar4,
- Shibani Mukerji1,
- Ross Zafonte5,
- Edward W Boyer6,
- C. Ron Yu7 and
- Mark W. Albers1,^
- 1Dept. of Neurology, Massachusetts General Hospital, Boston, MA 02129
- 2Dept. of Otolaryngology—Head and Neck Surgery, Mass. Eye and Ear, Boston, MA 02114
- 3Dept. of Psychology, Endicott College, Beverly, MA 01915
- 4The ADK Group, 11 Beacon Street, Boston MA 02108
- 5Dept. of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Boston, MA 02129
- 6Dept. of Emergency Medicine, Brigham and Women’s Hospital, Boston, MA 02115
- 7Stowers Institute of Medical Research, Kansas City, MO 64110
- ↵^Correspondence should be addressed to: Mark W. Albers, MassGeneral Institute of Neurodegenerative Disease, 114 16th St. #2003, Boston, MA 02129, T: 617-724-7401 F: 617-724-1480 Email: albers.mark{at}mgh.harvard.edu
Posted June 16, 2020.
Innate immune signaling in the olfactory epithelium reduces odorant receptor levels: modeling transient smell loss in COVID-19 patients
